Abiopharma

New Form 8-K - BioCardia, Inc. Filed: 2025-05-14 AccNo: 0001437749-25-016838 Size: 272 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Acrivon Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights

Alto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business Highlights

New Form 4 - INSULET CORP Filed: 2025-05-14 AccNo: 0001127602-25-014260 Size: 8 KB

New Form 10-Q - Gain Therapeutics, Inc. Filed: 2025-05-14 AccNo: 0001558370-25-007747 Size: 7 MB

New Form 8-K - CODEXIS, INC. Filed: 2025-05-14 AccNo: 0001193125-25-119847 Size: 240 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - HAWKINS INC Filed: 2025-05-14 AccNo: 0000046250-25-000024 Size: 410 KB Item 2.02: Results of Operations and Financial Condition

New Form PRE 14A - Entera Bio Ltd. Filed: 2025-05-14 AccNo: 0001178913-25-001794 Size: 1 MB

New Form 8-K - VERTEX PHARMACEUTICALS INC / MA Filed: 2025-05-14 AccNo: 0000875320-25-000194 Size: 168 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 3 - WEST PHARMACEUTICAL SERVICES INC Filed: 2025-05-14 AccNo: 0001127602-25-014257 Size: 9 KB

New Form 8-K - Adverum Biotechnologies, Inc. Filed: 2025-05-14 AccNo: 0001628280-25-025486 Size: 225 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - ADC Therapeutics SA Filed: 2025-05-14 AccNo: 0001628280-25-025481 Size: 6 MB

New Form SCHEDULE 13G/A - CalciMedica, Inc. Filed: 2025-05-14 AccNo: 0000935836-25-000330 Size: 19 KB

BeiGene Showcases Strength of Hematology Portfolio at EHA 2025 with New Data Highlighting BRUKINSA’s Leadership and Next-Generation Innovation

New Form 8-K - scPharmaceuticals Inc. Filed: 2025-05-14 AccNo: 0001193125-25-119842 Size: 207 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits